Hjem › Ægstockræft › Kansas
Ægstockræft kliniske forsøg i Kansas
10 studier for Ægstockræft søger deltagere på steder i Kansas.
Byer i Kansas
Officiel studietekst (engelsk)
DESTINY-PANTUMOUR04
- Research Site, Topeka
RekruttererObservationsstudie
Alder 18 til 130 · Alle køn · Opdateret 25. sep. 2026 · NCT07124000Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
- The University of Kansas Cancer Center, Westwood
RekruttererFase 2
Alder 18 og opefter · Kvinder · Opdateret 14. sep. 2026 · NCT06787612A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- University of Kansas Clinical Research Center, Fairway
- University of Kansas Cancer Center, Kansas City
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- og 1 flere
Rekrutterer
Alder 35 til 50 · Kvinder · Opdateret 7. aug. 2026 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- Mercy Hospital Pittsburg, Pittsburg
- og 1 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 7. aug. 2026 · NCT06580314Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- University of Kansas Medical Center (KUMC), Westwood
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 4. aug. 2026 · NCT05579366A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine
- University of Kansas Cancer Center, Fairway
RekruttererFase 1
Alder 18 og opefter · Kvinder · Opdateret 23. jul. 2026 · NCT03854110A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- The University of Kansas Cancer Center, Investigational Drug Services, Fairway
- The University of Kansas Clinical Research Center, Fairway
- The University of Kansas Hospital, Kansas City
- og 6 flere
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 6. jul. 2026 · NCT04389632Lead-212 PSV359 Therapy for Patients With Solid Tumors
- University of Kansas, Kansas City
RekruttererFase 1/2
Alder 18 til 90 · Alle køn · Opdateret 6. jul. 2026 · NCT06710756Integrated Cancer Repository for Cancer Research
- Saint Luke's Cancer Instititute - South, Overland Park
RekruttererObservationsstudieFrivillige med god helbredstilstand velkomne
Alder 19 til 110 · Alle køn · Opdateret 29. jun. 2026 · NCT02012699Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- University of Kansas Hospital, Kansas City
- University of Kansas Medical Center MOB, Kansas City
- University of Kansas Cancer Center Overland Park, Overland Park
- og 3 flere
RekruttererFase 3
Alder 18 og opefter · Kvinder · Opdateret 16. apr. 2026 · NCT05659381Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.